New

ETF model portfolios designed for real investor needs. Discover →

Advertisement
Advertisement

GNOMvsIBBETF Comparison

ETF 1
GNOM

Global X Genomics & Biotechnology ETF

This fund is part of
BioTech & Genomics
+0.29%
VS
ETF 2
IBB

iShares Biotechnology ETF

This fund is part of
US Health Care
-0.12%

Global X Genomics & Biotechnology ETF (GNOM) belongs to the BioTech & Genomics segment. iShares Biotechnology ETF (IBB) is part of the US Health Care segment. In contrast, IBB's top sector exposures are Healthcare, Non-Corporate and Non-Energy Materials. GNOM is more expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.44% for IBB. GNOM is up 36.95% year-to-date (YTD) with +$21M in YTD flows. IBB performs worse with 20.29% YTD performance, and +$363M in YTD flows. Run a side-by-side ETF comparison of GNOM and IBB below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

GNOM vs IBB performance and flow charts

Performance

0510%Aug 11Aug 18Aug 25Sep 1Sep 9

Cumulative Flows

-50 M0 M50 M100 M150 M200 M250 M300 MAug 11Aug 18Aug 25Sep 1Sep 9

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/11/2026
1M3MYTD1Y3Y5Y
Perf.
GNOM
IBB
+4.57%+1.54%
+27.28%+19.02%
+36.95%+20.29%
+69.95%+41.46%
+43.87%+60.28%
-32.85%+20.74%
Flows
GNOM
IBB
+$2M+$288M
+$18M+$782M
+$21M+$363M
+$15M+$1.85B
-$54M-$558M
-$42M-$1.34B
Volatility and drawdown
3M1Y3Y5Y
Volatility
GNOM
IBB
+37.85%+24.01%
+30.56%+21.76%
+30.36%+21.05%
+33.83%+22.47%
Max drawdown
GNOM
IBB
-8.57%-6.57%
-18.16%-9.61%
-43.10%-24.82%
-71.04%-38.96%
Max drawdown duration
GNOM
IBB
32d23d
145d151d
674d377d
1818d1523d
Trading data

Create an account to view trading data

Join for free
GNOM
IBB
Last sale
9/14/2026 at 1:30 PM
$63.57
$204.60
Previous close
09/11/2026
$62.22
$202.93
Consolidated volume
09/11/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
GNOM
IBB
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/14/2026 at 1:30 PM
Live
Closed
GNOM
IBB
Last price
$63.57
$204.60
1D performance
+2.17%
+0.82%
AuM$93.74 M$10.34 B
E/R0.5%0.44%
Characteristics
GNOM
IBB
Management strategyPassivePassive
ProviderGlobal XiShares
BenchmarkSolactive Genomics IndexICE Biotechnology Index
N° of holdings-240
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateApril 5, 2019February 5, 2001
ESGNoNo
Advertisement
Exposure

Countries

GNOM
Data will be available soon
IBB
USA
86.04%
Other
13.96%

Sectors

GNOM
Data will be available soon
IBB
Healthcare
99.83%
Other
0.17%
Advertisement

Diversification

GNOM
Data will be available soon
IBB

Total weight of top 15 holdings out of 15

54.48%

Top 15 holdings

Data as of January 1, 1970
GNOM
Data will be available soon
IBB
Amgen, Inc.
8.42%
Vertex Pharmaceuticals, Inc.
7.87%
Gilead Sciences, Inc.
7.14%
Regeneron Pharmaceuticals, Inc.
5.84%
argenx SE
3.55%
Natera, Inc.
2.88%
Revolution Medicines, Inc.
2.87%
Illumina, Inc.
2.42%
Biogen, Inc.
2.38%
Alnylam Pharmaceuticals, Inc.
2.14%
BeOne Medicines Ltd.
2.01%
Incyte Corp.
1.91%
Insmed, Inc.
1.71%
United Therapeutics Corp.
1.69%
Moderna, Inc.
1.65%
Frequently asked questions about GNOM and IBB

How have the GNOM and IBB ETFs performed in 2026?

As of September 11, 2026, GNOM is up 36.95% year-to-date (YTD), while IBB has returned 20.29%. That puts GNOM better performer ahead so far this year.

Which ETF is attracting more investor money: GNOM or IBB?

Year-to-date, the GNOM ETF saw +$21M in flows, compared to +$363M for IBB.

Which ETF is more volatile: GNOM or IBB?

Over the past year, GNOM had a volatility of 30.56%, while IBB experienced 21.76%.

Which ETF is bigger: GNOM or IBB?

As of September 11, 2026, GNOM holds $93.74 M in assets under management (AUM), while IBB manages $10.34 B.

Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder